In vivo activation of the SK channel in the spinal cord reduces the NMDA receptor antagonist dose needed to produce antinociception in an inflammatory pain model.

Pain
Lucia HipólitoZara Melyan

Abstract

N-methyl-D-aspartate receptor (NMDAR) antagonists have been shown to reduce mechanical hypersensitivity in animal models of inflammatory pain. However, their clinical use is associated with significant dose-limiting side effects. Small-conductance Ca-activated K channels (SK) have been shown to modulate NMDAR activity in the brain. We demonstrate that in vivo activation of SK channels in the spinal cord can alleviate mechanical hypersensitivity in a rat model of inflammatory pain. Intrathecal (i.t.) administration of the SK channel activator, 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309), attenuates complete Freund adjuvant (CFA)-induced mechanical hypersensitivity in a dose-dependent manner. Postsynaptic expression of the SK channel subunit, SK3, and apamin-sensitive SK channel-mediated currents recorded from superficial laminae are significantly reduced in the dorsal horn (DH) after CFA. Complete Freund adjuvant-induced decrease in SK-mediated currents can be reversed in vitro by bath application of NS309. In addition, immunostaining for the SK3 subunit indicates that SK3-containing channels within DH neurons can have both somatic and dendritic localization. Double immunostaining shows coexpression of SK3 and NMDAR subunit...Continue Reading

References

Jun 1, 1986·Journal of Neurophysiology·B Lancaster, P R Adams
Jul 1, 1994·Journal of Neuroscience Methods·S R ChaplanT L Yaksh
Jun 10, 2000·Science·C J Woolf, M W Salter
Jun 28, 2000·The Clinical Journal of Pain·D J Hewitt
May 17, 2002·Progress in Neurobiology·Pankaj Sah, E S Louise Faber
Aug 26, 2003·Advanced Drug Delivery Reviews·Carolyn A Fairbanks
Mar 18, 2004·Acta Anaesthesiologica Scandinavica·A KanaiQ Hogan
Apr 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Parmvir K BahiaGuy W J Moss
Apr 27, 2005·Nature Neuroscience·Thu Jennifer Ngo-AnhJohn P Adelman
Jul 5, 2005·Nature Reviews. Neuroscience·Maria Fitzgerald
Oct 4, 2005·European Journal of Pain : EJP·Alex W WilsonIain P Chessell
Feb 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carole Torsney, Amy B MacDermott
Jan 18, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrew D McClellanDavid J Schulz
Sep 26, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Miklós AntalRyuichi Shigemoto
Dec 23, 2008·FEBS Letters·Marilou A AndresThomas Zeyda
Oct 20, 2009·Cell·Allan I BasbaumDavid Julius
Apr 3, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Max Larsson, Jonas Broman
Sep 29, 2011·Annual Review of Physiology·John P AdelmanPankaj Sah
Nov 11, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan XiaJose A Morón
Nov 15, 2011·Current Opinion in Pharmacology·Jürgen Sandkühler, Doris Gruber-Schoffnegger
May 4, 2012·Journal of Neurophysiology·Bridget M McKayJohn F Disterhoft

❮ Previous
Next ❯

Citations

Mar 10, 2021·Organic & Biomolecular Chemistry·Charlotte M SevrainPaul-Alain Jaffrès

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.